P782: A PHASE 2, RANDOMIZED TRIAL EVALUATING THE SAFETY AND EFFICACY OF POZELIMAB AND CEMDISIRAN IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA

Authors: Jun-Ho Jang, Raymond Wong, Rodrigo Pavani, Lisa Aurand, Quang P. Nguyen, Lorah Perlee, Amal Souttou, Jonathan Weyne, Richard Kelly

Source: HemaSphere, Vol 7, p e0181707 (2023)

Subject Terms: Diseases of the blood and blood-forming organs, RC633-647.5

File Description: electronic resource

Relation: http://journals.lww.com/10.1097/01.HS9.0000970032.01817.07; https://doaj.org/toc/2572-9241

Access URL: https://doaj.org/article/d94b44a429864d05ac0d776924e7033d

P797: A PHASE 2, OPEN-LABEL STUDY EVALUATING THE SAFETY AND EFFICACY OF COMBINATION POZELIMAB AND CEMDISIRAN THERAPY IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA WHO SWITCH FROM ECULIZUMAB

Authors: Richard Kelly, Nicola Houghton, Talha Munir, Petra Muus, Nora Youngs, Lisa Aurand, Brian Senk, Rodrigo Pavani, Lorah Perlee, Amal Souttou, Morag Griffin

Source: HemaSphere, Vol 7, p e6873083 (2023)

Subject Terms: Diseases of the blood and blood-forming organs, RC633-647.5

File Description: electronic resource

Relation: http://journals.lww.com/10.1097/01.HS9.0000970092.68730.83; https://doaj.org/toc/2572-9241

Access URL: https://doaj.org/article/0619e6938917410e96f0408b6543771a